title: The Intensive Vaccines Monitoring Programme (IVMP): an electronic system to monitor vaccine safety in New Zealand.
abstract: New Zealand introduced a tailor-made vaccine (MeNZB) for epidemic control of Group B meningococcal disease. The Intensives Vaccine Monitoring Programme (IVMP), which prospectively collected data electronically on a cohort of children receiving vaccinations in sentinel practices across NZ, was developed as part of a national multi-faceted safety strategy. The main aim of the IVMP was to identify the presence of unexpected adverse events occurring with MeNZB vaccination. We describe the methodology and success factors plus consider the limitations encountered in this system which shows potential as a means for post-marketing vaccine and medicine surveillance in the future.
authors.affiliation: New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand. michael.tatley@otago.ac.nz
authors.forename: Michael V
authors.initials: MV
authors.lastname: Tatley
authors.forename: Desireé L
authors.initials: DL
authors.lastname: Kunac
authors.forename: Anne
authors.initials: A
authors.lastname: McNicholas
authors.forename: Lifeng
authors.initials: L
authors.lastname: Zhou
authors.forename: Suzie
authors.initials: S
authors.lastname: Ballantyne
authors.forename: Janelle
authors.initials: J
authors.lastname: Ashton
authors.forename: Paul
authors.initials: P
authors.lastname: Stehr-Green
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Galloway
authors.forename: Stewart
authors.initials: S
authors.lastname: Reid
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D004582:Electronics, Medical; D006801:Humans; D007223:Infant; D022401:Meningococcal Vaccines / Q000009:adverse effects*; D009520:New Zealand; D011358:Product Surveillance, Postmarketing / Q000379:methods*
chemical_list: D022401:Meningococcal Vaccines